STARGARDT
Clinical trials for STARGARDT explained in plain language.
Never miss a new study
Get alerted when new STARGARDT trials appear
Sign up with your email to follow new studies for STARGARDT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial offers hope for stargardt disease patients
Disease control Recruiting nowThis early study tests a new gene therapy drug, ZVS106e, for people with a rare inherited eye disease called Stargardt disease, which causes vision loss. The treatment is given as a single injection under the retina in one eye. The main goal is to check if it is safe, and researc…
Matched conditions: STARGARDT
Phase: EARLY_PHASE1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 10:23 UTC
-
Researchers watch stargardt eye disease progress in 75 patients
Knowledge-focused Recruiting nowThis study follows 75 people with Stargardt disease type 1, a genetic eye condition that causes vision loss. Researchers will use eye scans and vision tests over time to measure how the disease progresses. The goal is to better understand the disease's natural course, which can h…
Matched conditions: STARGARDT
Sponsor: Splice Bio • Aim: Knowledge-focused
Last updated May 26, 2026 10:21 UTC